Revenue
attach_money0M USD
-
CADLCandel Therapeutics, Inc.$ --
Candel Therapeutics, Inc.
CADL
$ -
-
Review earnings summary, surprise history, and upcoming forecasts.
analyticsEarnings Summary
FY2025 Q4Updated: 12/31/2025
Operating Income
trending_up-16M USD
-
Net Income
verified-29M USD
-
EPS
paid-0.54$
-
Revenue
$0
NO FORECAST
Q1
Q2
Q3
Q4
Cumulative
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-
Net Income
$-29.5M
MISS
$7.4M
Q1
$-4.8M
$-10.2M
$-11.3M
$-13.4M
$-29.5M
$-23.6M
$-38.2M
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-
Surprise History
ActualEstimate
FY2025MISS